Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Hypertension (Dallas, Tex. : 1979)|July 30, 2014
Differences in cell-type-specific responses to angiotensin II explain cardiac remodeling differences in C57BL/6 mouse substrainsSophie Cardin, Marie-Pier Scott-Boyer, Samantha Praktiknjo, et al.Molecular and Cellular Biochemistry|January 8, 2010
Early predictors of cardiac decompensation in experimental volume overloadChristelle Oliver-Dussault, Alexis Ascah, Mariannick Marcil, et al.Cell Reports|October 6, 2016
Association of a Network of Interferon-Stimulated Genes with a Locus Encoding a Negative Regulator of Non-conventional IKK Kinases and IFNB1Saloua Jeidane, Marie-Pier Scott-Boyer, Nicolas Tremblay, et al.British Journal of Clinical Pharmacology|December 22, 2016
The drugs that mostly frequently induce acute kidney injury: a case - noncase study of a pharmacovigilance databaseMarion Pierson-Marchandise, Valérie Gras, Julien Moragny, et al.Therapie|December 30, 2020
[Adverse drug reactions profiles for abiraterone and enzalutamide: A pharmacovigilance descriptive analysis]Lucie-Marie Scailteux, Clémence Lacroix, Sandrine Bergeron, et al.Lancet (London, England)|June 12, 2012
Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trialPablo Aschner, Juliana Chan, David R Owens, et al.Microbes and Environments|November 13, 2022
Occurrence and Diversity of Listeria monocytogenes Isolated from Two Pig Manure Treatment Plants in FranceMartine Denis, Christine Ziebal, Evelyne Boscher, et al.Journal of Diabetes and Its Complications|October 7, 2014
Triple combination of insulin glargine, sitagliptin and metformin in type 2 diabetes: the EASIE post-hoc analysis and extension trialJuliana C N Chan, Pablo Aschner, David R Owens, et al.Journal of Diabetes Science and Technology|October 5, 2025
Use of the Glycemia Risk Index at Hybrid Closed-Loop Initiation to Predict Combined International Glucose Targets at 12 Months: Results From the CIRDIA Study GroupSylvie Picard, Joëlle Dupont, Fabienne Amiot-Chapoutot, et al.Diabetes & Metabolism|February 8, 2025
Glycemia Risk Index (GRI) and international glucose targets before and 6 months after initiation of hybrid closed loop system in the CIRDIA, a French multisite out-of-hospital centerSylvie Picard, Blandine Courbebaisse, Joëlle Dupont, et al.Pageof 4